Determination of Glycemic Index (GI) of Ten Food Products

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Danone Asia Pacific Holdings Pte, Ltd.
ClinicalTrials.gov Identifier:
NCT01679704
First received: August 30, 2012
Last updated: September 5, 2012
Last verified: September 2012
  Purpose

This study is initiated to investigate the glycemic index value of ten food products.


Condition Intervention
Glycemic Index
Dietary Supplement: Food products

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Determination of Glycemic Index (GI) of Ten Food Products

Further study details as provided by Danone Asia Pacific Holdings Pte, Ltd.:

Primary Outcome Measures:
  • Glycemic index values of all ten products [ Time Frame: 120 minutes post adminstration ] [ Designated as safety issue: No ]
    Glycemic index values at 120 minutes post adminstration.


Enrollment: 15
Study Start Date: August 2012
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Food products
Ten food products will be given to all subjects
Dietary Supplement: Food products

  Eligibility

Ages Eligible for Study:   21 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy non-pregnant females (at least 6 weeks postpartum, non-lactating)
  • Age between 21 to 60 years

Exclusion Criteria:

  • Suffering from any chronic diseases.
  • Suffering from gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism and excretion.
  • History of diabtes mellitus or use of antihyperglycemic drugs or insulin to treat diabetes and related conditions.
  • History of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism.
  • Current use of medication that may interfere with the digestion and nutrient absorption (for examples steriods, protease inhibitors or antipsychotics medications).
  • Current use of medication known to affect glucose tolerance (excluding oral contraceptives).
  • Known food allergy or intolerance.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01679704

Locations
Singapore
Temasek Polytechnic
Singapore, Singapore
Sponsors and Collaborators
Danone Asia Pacific Holdings Pte, Ltd.
Investigators
Principal Investigator: Kalpana Bhaskaran, Dr Temasek Polytechnic
  More Information

No publications provided

Responsible Party: Danone Asia Pacific Holdings Pte, Ltd.
ClinicalTrials.gov Identifier: NCT01679704     History of Changes
Other Study ID Numbers: GIS.2012
Study First Received: August 30, 2012
Last Updated: September 5, 2012
Health Authority: Singapore: Ministry of Health

ClinicalTrials.gov processed this record on July 22, 2014